European Association for the Study of the Liver (EASL) Liver Congress (2022)

Digital quantitation of fibrosis, septa parameters and treatment-induced changes in metabolic dysfunction-associated steatohepatitis F3 fibrosis

Comparing fibrosis distribution in lean versus overweight/obese NASH-cirrhosis patients using SHG/TPE microscopy: An observational analysis

Artificial Intelligence to Measure Fibrosis Change on Liver Biopsy in MAESTRO-NASH, a Phase 3 52-Week Serial Liver Biopsy Study in 966 Patients With NASH Treated With Resmetirom or Placebo